Latest News about REGN
Recent news which mentions REGN
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
September 30, 2024
From Benzinga
Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
September 29, 2024
From Benzinga
From Benzinga
Taiwan Semiconductor, American Tower, Trane Technologies And A Health Care Stock On CNBC's 'Final Trades'
September 26, 2024
From Benzinga
A Closer Look at Regeneron Pharmaceuticals's Options Market Dynamics
September 25, 2024
Tickers
REGN
From Benzinga
Exploring The Competitive Space: Regeneron Pharmaceuticals Versus Industry Peers In Biotechnology
September 25, 2024
From Benzinga
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
September 25, 2024
From Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower On Tuesday?
September 24, 2024
From Benzinga
This BP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
September 24, 2024
From Benzinga
Competitor Analysis: Evaluating Regeneron Pharmaceuticals And Competitors In Biotechnology Industry
September 11, 2024
From Benzinga
Sanofi, Regeneron Drug Dupixent Shows Successful Treatment Of Patients With Inflammatory Skin Disease
September 11, 2024
From Benzinga
Prediction: These 2 Companies Will Split Their Stocks by 2027
September 11, 2024
From Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,000 Today
September 10, 2024
From Benzinga
Beyond The Numbers: 20 Analysts Discuss Regeneron Pharmaceuticals Stock
September 09, 2024
Tickers
REGN
From Benzinga
Prediction: These 2 Cathie Wood Stocks Could Crush the Market Through 2030
September 05, 2024
From Motley Fool
From Benzinga
What Analysts Are Saying About Regeneron Pharmaceuticals Stock
August 23, 2024
Tickers
REGN
From Benzinga
From Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $130 Thousand Today
August 20, 2024
From Benzinga
7 Stocks That Usually Benefit From a Recession
August 13, 2024
From InvestorPlace
Insights Into Regeneron Pharmaceuticals's Performance Versus Peers In Biotechnology Sector
August 13, 2024
From Benzinga
From InvestorPlace
From Benzinga
3 Biotech Stocks With Promising Drug Pipelines: August 2024
August 08, 2024
From InvestorPlace
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.